Mon panier

IL-10

IL-10 Informations sur la molécule

Nom anglaisInterleukin-10Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9Alias de la cibleInterleukin 10,IL-10,IL10,CSIF,Cytokine Synthesis Inhibitory Factor,T-Cell Growth Inhibitory Factor,Interleukin-10,GVHDS,IL10A,TGIF
Phase de R&D la plus avancéePhase 3 Clinical
Nom anglaisInterleukin-10
Alias de la cibleInterleukin 10,IL-10,IL10,CSIF,Cytokine Synthesis Inhibitory Factor,T-Cell Growth Inhibitory Factor,Interleukin-10,GVHDS,IL10A,TGIF
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9
Phase de R&D la plus avancéePhase 3 Clinical

IL-10 Liste de produits

  • Attribut

    Protein (7)Kits (3)

  • Bibliothèque de produits

    En ligne (9)En recherche (1)

  • Espèces

    Human (7)Mouse (2)Cynomolgus (1)

  • Étiquette

    His Tag (3)- (3)Tag Free (3)His Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (6)- (3)Biotin-labeled (1)

IL-10Contexte de la molécule

Interleukin-10 (IL-10) is also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. IL-10 is an immunosuppressive cytokine produced by a variety of mammalian cell types including macrophages, monocytes, T cells, B cells and keratinocytes. Mature human IL-10 shares 72% - 86% amino acid sequence identity with bovine, canine, equine, feline, mouse, ovine, porcine, and rat IL-10. Whereas human IL-10 is active on mouse cells, mouse IL-10 does not act on human cells. IL-10 is capable of inhibiting synthesis of pro-inflammatory cytokines such as IFN-γ, IL-2, IL-3, TNFα and GM-CSF made by cells such as macrophages and regulatory T-cells. It also displays a potent ability to suppress the antigen-presentation capacity of antigen presenting cells. However, it is also stimulatory towards certain T cells and mast cells and stimulates B cell maturation and antibody production. Knockout studies suggested the function of Interleukin-10 / IL-10 as an essential immunoregulator in the intestinal tract. Patients with Crohn's disease react favorably towards treatment with bacteria producing recombinant interleukin-10, showing the importance of interleukin-10 for counteracting excessive immunity in the human body.

IL-10Alias de la molécule

CSIF,IL-10,IL10A,TGIF,B-TCGF,GVHDS,MGC126450,MGC126451,RP11-262N9.1,Interleukin-10

Coopération sous licence

Nom du projetType de médicamentDomain thérapeutiqueIndicationPhaseZone de droits
IL10 / IL10RA mAbMonospecific antibodyInfectious and parasitic diseasesImmunodeficienciesPCCGlobal

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
SFA-002SFA-002; SFA002Phase 3 ClinicalSFA Therapeutics IncArthritis, Rheumatoid; Plaque psoriasis; Psoriasis
Details
Mesenchymal stem cells therapy (Therapeutic Solutions International)Phase 3 ClinicalJadi Cell LLCCoronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult
Details
KLS-2031KLS-2031Phase 2 ClinicalKolon Life Science. IncNeuralgia; Radiculopathy
Details
WP-1303 (worgpharma)ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825APhase 2 ClinicalApitope TechnologyMultiple Myeloma; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Details
TRX-103TRX-103; TRX103Phase 2 ClinicalTr1X IncCrohn Disease; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic stem cell transplantation (HSCT); Inflammatory Bowel Diseases; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uveitis
Details
Faecalibacterium prausnitzii EXL01 (Exeliom)EXL-01; EXL01Phase 2 ClinicalExeliom BiosciencesBacterial Infections; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Clostridium Infections; Crohn Disease; Stomach Neoplasms
Details
XT-150XT-101; XT-150; XT-101-RPhase 2 ClinicalXalud Therapeutics IncAmyotrophic Lateral Sclerosis; Arthralgia; Back Pain; Inflammation; Multiple Sclerosis; Neuralgia; Osteoarthritis, Knee; Osteoarthritis, Spine
Details
Anti-CD19 IL10 CAR-NK cell therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineLymphoma, B-Cell
Details
FP-008 (Fapon Biotech)FP-008; FP008Phase 1 ClinicalGuangdong Fapon Biopharma IncNeoplasms; Solid tumours
Details

Avis sur les produits

  • S***a2024-05-09
    0Mettre un like
    We often purchase cytokines from Acro. Acro has been great with its shipments so far and we like the proteins we get from Acro because they are always of very good quality. We use these proteins to run a multitude of assays and we've never run into any problems. For a small startup like ours getting good quality reagents for affordable prices is extremely helpful and we get that from Acro. We also believe we will be sticking with Acro's proteins :) Thank you, Acro!
  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques